Search

Gene therapy gets big pharma endorsement

Gene therapy is poised to make a commercial breakthrough after Oxford BioMedica agreed global rights for a cancer treatment with Sanofi-Aventis, in a deal with a headline value of €518 million.

Innovate or enervate?

The latest stop for the Science|Business road show had leading lights in EU policy arguing about what it takes to create a European innovation zone.